NCT00517816View on ClinicalTrials.gov

A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Asthma
Interventions
DRUG

RG1671

Administered iv at escalating doses (with a starting dose of 0.0015mg)

Trial Locations (8)

27560

Morrisville

32127

Port Orange

42431

Madisonville

61761

Normal

72204

Little Rock

78209

San Antonio

91606

North Hollywood

02747

North Dartmouth

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00517816 - A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma. | Biotech Hunter | Biotech Hunter